Evidence map›Paper›PMID 42718557›Full record

ArticleFrontiers in oncology2026

Diagnostic value of peripheral blood leukocyte parameters, NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, and NE-SFL, in lung cancer.

Wenqian Tian, Youhua Yuan, Yahui Hu, Lu Bai, Lan Gao

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wenqian Tian *Department of Special Laboratory, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan, China.
Youhua Yuan *Department of Special Laboratory, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan, China.
Yahui Hu *Medical Clinical Laboratory, The Fifth Clinical Medical College of Henan University of Chinese Medicine/Zheng Zhou People's Hospital, Zhengzhou, Henan, China.
Lu BaiMedical Records Office, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan, China.
Lan GaoDepartment of Special Laboratory, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: We aimed to assess the diagnostic potential of six leukocyte parameters (NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, and NE-SFL) for lung cancer by analysing 423 patients, 39 benign cases, and 346 healthy controls. Methods: The results of these six leukocyte parameters were compared among groups using the Kruskal-Wallis H test. Multivariate logistic regression was used to analyze correlations between NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, NE-SFL, and lung cancer diagnosis. Patients were randomly grouped into training and testing sets, and nine machine-learning models (support vector machine, gradient boosting machine, artificial neural network, random forest [RF], extreme gradient boosting, K-nearest neighbor, adaptive boosting, light gradient boosting machine, and catboost) were built to compare the diagnostic performances. The DeLong test was adopted to compare the area under the receiver operating characteristic curve (AUC) values among nine machine learning models. Results: These six leukocyte parameter levels differed significantly between the lung cancer and control groups. Multivariate logistic regression revealed a strong predictive value of NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, and NE-SFL for lung cancer. NE-WX and NE-SFL were independent risk predictors. Receiver operating characteristic analysis revealed that MO-Y was the best diagnostic single indicator for lung cancer (AUC = 0.787, specificity=82.0%). The combination of LY-Y, MO-Y, MO-Z, and NE-SFL demonstrated superior diagnostic efficacy (AUC = 0.897, sensitivity=70.6%, specificity=78.9%, Youden index=0.495) compared with any single indicator. The RF model exhibited high consistency between predicted and actual values, demonstrating robust and reliable predictive performance in lung cancer diagnosis. MO-Y and MO-Z were the top predictive biomarkers with the strongest predictive value. Conclusions: NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, and NE-SFL may aid in diagnosis of lung cancer. The RF model demonstrates strong potential for lung cancer detection.

Indexed as

biomarkerscell population datadiagnostic valuelung cancermachine learning

Identifiers

PMID42718557
PMCPMC13553461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.